|
|
EGG PHOSPHOLIPIDS Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
EDETATE CALCIUM DISODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
DOCUSATE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
AMMONIUM GLYCYRRHIZATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|